GnRH antagonist + Letrozole for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Jul 2022: Trial started, NCT06390904
  2. 30 Apr 2024: Trial registered, NCT06390904

The trials

NCT06390904: GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

State
Under way
Phase
Phase 2 and Phase 3
People
29 planned
Started
13 Jul 2022
Primary completion
30 Jul 2025
Arms
Obese EAH group
Results
None posted
  1. 13 Jul 2022: Trial started
  2. 30 Apr 2024: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.